Compounds and uses thereof
US7005434B2 · kind B2 · utility
0Cited by
2References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 18, 2002 |
| Grant date | Feb 28, 2006 |
| Priority date | — |
| Expiry date | Jan 18, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds and the treatment of mammalian diseases in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.